As COVID-19 has been shown to adversely affect patients with cancer, prophylactic
strategies are critically needed. We determined the immunogenicity of COVID-19 …

As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …

Background Coronavirus disease 2019 (COVID-19) has affected> 210 million people
worldwide. An optimal therapeutic approach for COVID-19 remains uncertain, to date. Since …

We and others have shown the significant impact of COVID-19 infection among patients with
a cancer diagnosis, with increased morbidity and mortality with advanced age, co …

Background Patients with cancer, particularly those undergoing chemotherapy, are at risk
from the low immunogenicity of Coronavirus Disease 19 (COVID-19) vaccines. Methods This …

Patients with cancer are among the most vulnerable groups of the COVID-19 pandemic,
whereas vaccinations can represent a cornerstone in overcoming the pandemic itself …

Background Vaccination is an important preventive health measure to protect against
symptomatic and severe COVID-19. Impaired immunity secondary to an underlying …

Vaccines against COVID-19 have demonstrated a remarkable efficacy in decreasing
hospitalisations and deaths; however, clinical trials leading to vaccine approvals did not …

Abstract Background Although SARS-CoV-2 vaccines immunogenicity in patients with
cancer has been investigated, whether they can significantly improve the severity of COVID …

Background: The effective development of COVID-19 vaccination has mitigated its harm.
Using two laboratory methods, we investigated the efficacy of the BNT162b2 mRNA and …